During the past decade, Complete Healthcare for Women conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complete Healthcare for Women" #1 sponsor was "Astellas Pharma Global Development, Inc." with 2 trials, followed by "Hologic, Inc." with 2 trials sponsored, "Sequenom, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Curatek Pharmaceuticals, LLC" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complete Healthcare for Women" #1 collaborator was "Clinical Research Management, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Complete Healthcare for Women" are "Endometriosis" (3 trials), "Down Syndrome" (2 trials), "Hot Flashes" (2 trials), "Menorrhagia" (2 trials) and "Uterine Fibroids" (2 trials). Many other conditions were trialed in "Complete Healthcare for Women" in a lesser frequency.

Most popular intervention types in "Complete Healthcare for Women" are "Drug" (13 trials), "Device" (5 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials) and "Placebo capsule to match Add-back capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Complete Healthcare for Women" are 20 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Complete Healthcare for Women". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Complete Healthcare for Women, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Complete Healthcare for Women, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".